Endothelin-1 impairs alveolar epithelial function via endothelial ETB receptor

Area of Science:

• Pulmonary Medicine
• Cellular Biology
• Endocrinology

Background:

• Elevated endothelin-1 (ET-1) levels are observed in conditions like high-altitude pulmonary edema and acute respiratory distress syndrome.
• These conditions are characterized by impaired alveolar fluid reabsorption (AFR).

Purpose of the Study:

• To investigate if ET-1 reduces AFR through endothelial cell activation and nitric oxide (NO) generation.
• To elucidate the specific mechanisms and cellular interactions involved in ET-1's effect on AFR.

Main Methods:

• Utilized isolated perfused rat lungs and transgenic rats lacking ETB receptors.
• Employed coincubation models of human microvascular endothelial cells (HMVEC-L) with rat alveolar epithelial cells or A549 cells.
• Assessed Na,K-ATPase activity using ouabain-sensitive 86Rb+ uptake.

Main Results:

• ET-1's reduction of AFR was blocked by inhibiting the ETB receptor, not ETA.
• Endothelial-epithelial cell interaction was crucial; direct ET-1 exposure to epithelial cells did not alter Na,K-ATPase function.
• ET-1 increased NO production in HMVEC-L, and this effect on Na,K-ATPase was mitigated by a nitric oxide synthase inhibitor.

Conclusions:

• ET-1, through endothelial-epithelial interaction, decreases AFR.
• This process involves ETB receptor activation and NO generation, leading to alveolar epithelial Na,K-ATPase downregulation.
• The mechanism is independent of cyclic guanosine monophosphate (cGMP).